Mizunuma H相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

每月口服100毫克伊班膦酸钠与每月静脉注射1毫克伊班膦酸钠治疗日本原发性骨质疏松症患者的临床疗效和安全性比较

期刊:Osteoporosis International

影响因子:5.4

doi:10.1007/s00198-015-3175-1

Nakamura, T; Ito, M; Hashimoto, J; Shinomiya, K; Asao, Y; Katsumata, K; Hagino, H; Inoue, T; Nakano, T; Mizunuma, H

发表日期：2015

文献求助收藏

Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers.

5-氨基乙酰丙酸甲酯在光动力疗法治疗卵巢癌中的疗效

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-010-0761-7

Wakui M, Yokoyama Yoshihito, Wang H, Shigeto T, Futagami M, Mizunuma H

发表日期：2010

文献求助收藏

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours

环氧合酶-2和过氧化物酶体增殖物激活受体γ在卵巢上皮肿瘤中的表达的临床意义

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/sj.bjc.6602009

Sakamoto, A; Yokoyama, Y; Umemoto, M; Futagami, M; Sakamoto, T; Bing, X; Mizunuma, H

发表日期：2004

文献求助收藏

Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency

对日本果糖-1,6-二磷酸酶缺乏症患者进行基因突变鉴定

期刊:American Journal of Human Genetics

影响因子:8.1

doi:10.1086/514875

Kikawa, Y; Inuzuka, M; Jin, B Y; Kaji, S; Koga, J; Yamamoto, Y; Fujisawa, K; Hata, I; Nakai, A; Shigematsu, Y; Mizunuma, H; Taketo, A; Mayumi, M; Sudo, M

发表日期：1997

文献求助收藏